Incyte | INCY - Ebitda





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amgen USD 3.86B 1.28B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Exelixis USD 255.4M 2.89M 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD -1.54B 7.84B 2026-03
Moderna USD -1.26B 468M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06